COMP <GO>
LH vs MRK // FREE CASH FLOW YIELD
Labcorp Holdings Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: LH 5
— MRK 10
▲ FREE CASH FLOW YIELD LEADER: LH
LAST: $361.39 (-1.84%) • MKT CAP: $29.86B
fcf-yield
4.04%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LH VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LH | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.80% | 74.80% | -46.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.30% | 20.70% | -12.40 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.6x | 15.3x | +4.30 | MRK | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 4.04% | 3.42% | +0.62 | LH | /fcf-yield <GO> |
| Operating Margin | 9.90% | 34.30% | -24.40 | MRK | /operating-margins <GO> |
| Net Profit Margin | 6.30% | 28.10% | -21.80 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 7.20% | 1.30% | +5.90 | LH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.81% | 2.26% | -1.45 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.58 | 5.19 | -1.61 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | LH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.60% | +0.20 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.5 | 56.9 | +17.68 | LH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.92 | +0.04 | LH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.6x | 18.4x | +13.20 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $29.86B | $361.02B | -$331.16B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LH REV | MRK REV | LH GROSS % | MRK GROSS % | LH FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.95B | $65.01B | 28.8% | 74.8% | $1.21B | $12.36B |
| FY 2024 | $13.01B | $64.17B | 27.9% | 76.3% | $1.10B | $18.10B |
| FY 2023 | $12.16B | $60.12B | 44.0% | 44.0% | $780.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LH // BETA 0.96
MRK // BETA 0.92